Cytokine Release Syndrome Evaluation Study

With JAX’s Cytokine Release Syndrome (CRS) evaluation platform, you can move to an IND filing with more confidence about the safety of your therapeutic prior to entering clinical trials. With our novel humanized mouse platform, you can test candidate therapeutics in the presence of tumor, multiple donors, and multiple doses, testing for both immunotoxicity and drug efficacy in the same study.